Immediate Impact
4 from Science/Nature 60 standout
Citing Papers
Current best practice for bladder cancer: a narrative review of diagnostics and treatments
2022 Standout
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
2021 Standout
Works of Bruce E. Spotts being referenced
Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma
2000
Survival of patients with carcinoma in situ of the urinary bladder
1999
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Bruce E. Spotts | 324 | 116 | 78 | 118 | 8 | 464 | |
| Stephen J. Schultenover | 77 | 17 | 57 | 232 | 15 | 419 | |
| M Di Muzio | 60 | 8 | 178 | 172 | 15 | 462 | |
| S. T. Bartlett | 298 | 3 | 69 | 146 | 14 | 567 | |
| Mohammad Faroja | 87 | 21 | 44 | 29 | 10 | 516 | |
| Christine B Du | 237 | 19 | 170 | 108 | 9 | 546 | |
| Gracia Sarrión | 106 | 13 | 61 | 100 | 8 | 538 | |
| Spasenija Savic-Prince | 354 | 81 | 57 | 158 | 5 | 429 | |
| Evelyne C. C. Cauberg | 310 | 68 | 86 | 40 | 12 | 442 | |
| Osama Shahin | 500 | 199 | 65 | 60 | 7 | 542 | |
| Cristina Bordea | 51 | 5 | 10 | 304 | 10 | 491 |
All Works
Loading papers...